Immune Checkpoint Inhibitor
Oncology
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| GilvetMab | Merck & Co., Inc. (MRK) |
Phase 3(1)
| Drug | Company |
|---|---|
| Plinabulin | BeyondSpring Inc. (BYSI) |
Phase 1(1)
| Drug | Company |
|---|---|
| PLN-101095 | PLIANT THERAPEUTICS, INC. (PLRX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Immune Checkpoint Inhibitor?
BioSniper tracks 3 drugs in development for Immune Checkpoint Inhibitor across 3 companies.
How many clinical trials target Immune Checkpoint Inhibitor?
There are 2 clinical trials targeting Immune Checkpoint Inhibitor tracked by BioSniper.
Deep-dive into Immune Checkpoint Inhibitor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis